Canadian CANNAINVESTOR Magazine May / June 2018 | Page 252

270

252

CASE STUDY 2

Let’s start off by clearly and unequivacably staing that Alliance Growners Corp (ACG) did not request this case study nor was there any compensation or consideration of any kind offered or recevied or even discussed for this case study.

To all of the paid promoters/influencers and short sellers operating under the guise as analysts – see how easy it is to put that disclosure at the top?

For those new to our magazine I welcome you so for you as well as those who did not read the Q&A last month with ACG or read that issue’s content I strongly urge you to do so now.

ACG has a very respectable public float of shares once you factor in insiders’ holdings (always refer to www.sedi.ca for insider transactions) and a very attractive market capitlization.

There are two pieces of recent news that warrant specific attention.

1) ACG to expand capacity of Cannabis Botany Centre.

That centre will be expanded to 58,000ft2 from 40,000ft2. This will allow up to 10-million plantlets to be sold for approximately $5 each. ACG estimates that will project to $40M in annual profits from this one business line. Note however that ACG’s stake is 30% at time of writing.

2) ACG advances Quebec ACMPR application.

ACG moved quickly to close the deal and wholly own late stage applicant BioCannaTech.

ACG states that they expect the facility to be licensed as early as mid-October 2018.

Through their business partnership with Pharmagreen – “the two companies have agreed to the joint development of the proprietary high yield CBD DANA strain in a profitable industrial hemp operation that begins with tissue culture plantlets produced and grown on what is now referred to as the Cannabis Biotech Complex on the property in Mission BC”.

Alliance Growers Corp.

CSE:ACG; FRA:1LA

As At May 11, 2018

Shares Outstanding: 64,843,890 (www.tmxmoney.com)

Share Price: $0.26 Market Cap: $16,859,411.40

View current Pitch Presentation